An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
Diseases of the Cardiovascular System
What is the purpose of this trial?
This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.
- Ages18 years and older
- Trial withGE Healthcare
- Start Date01/29/2019
- End Date08/30/2020
- Last Updated03/01/2019
- Study HIC#2000023850